tiprankstipranks
Trending News
More News >
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
US Market
Advertisement

Dianthus Therapeutics (DNTH) Financial Statements

Compare
385 Followers

Dianthus Therapeutics Financial Overview

Dianthus Therapeutics's market cap is currently $1.37B. The company's EPS TTM is $-0.88; its P/E ratio is ―; Dianthus Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.89. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Dianthus Therapeutics Earnings and Revenue History

Dianthus Therapeutics Debt to Assets

Dianthus Therapeutics Cash Flow

Dianthus Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis